Pneumomed s.r.o.
- Address
- Einsteinova 25, 851 01 Bratislava, Slovakia
Eye Diseases
At Pneumomed s.r.o. in Bratislava, clinical research in ophthalmology focuses on diabetic macular edema and wet age-related macular degeneration, with studies aimed at improving vision outcomes and comparing new eye treatments with established care.
- Diabetic macular edema and wet age-related macular degeneration
- Testing whether new retinal therapies can improve best corrected visual acuity
- Comparing emerging eye treatments with standard anti-VEGF therapy
These trials are designed to help determine whether newer approaches can deliver similar or better control of vision loss in common retinal diseases.
Respiratory Tract Diseases
Clinical trials at this site also cover pulmonology, especially moderate-to-severe chronic obstructive pulmonary disease, where researchers are evaluating new ways to reduce flare-ups and improve day-to-day disease control.
- Moderate-to-severe chronic obstructive pulmonary disease
- Assessing treatments that may lower COPD exacerbations
- Exploring better control of long-term breathing symptoms
This work focuses on whether investigational therapies can offer meaningful relief for people living with persistent respiratory disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Eyepoint Inc.1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Eyepoint Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Pneumomed s.r.o.
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 to Aflibercept in Participants with Diabetic Macular Edema | Eyepoint Inc. | Phase III | Recruiting | May 2026 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aflibercept | 4 | Unknown | 2025-06-05 | 2026-06-22 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.